Clinical features and outcomes of gastric variceal bleeding: retrospective Korean multicenter data
2
조회
0
다운로드
10
인용
0
참고문헌
키워드
초록
Background/Aims: While gastric variceal bleeding (GVB) is not as prevalent as esophageal variceal bleeding, it is reportedly more serious, with high failure rates of the initial hemostasis (>30%), and has a worse prognosis than esophageal variceal bleeding. However, there is limited information regarding hemostasis and the prognosis for GVB. The aim of this study was to determine retrospectively the clinical outcomes of GVB in a multicenter study in Korea. Methods: The data of 1,308 episodes of GVB (males:females=1062:246, age=55.0±11.0 years, mean±SD) were collected from 24 referral hospital centers in South Korea between March 2003 and December 2008. The rates of initial hemostasis failure, rebleeding, and mortality within 5 days and 6 weeks of the index bleed were evaluated. Results: The initial hemostasis failed in 6.1% of the patients, and this was associated with the Child-Pugh score [odds ratio (OR)=1.619; P<0.001] and the treatment modality: endoscopic variceal ligation, endoscopic variceal obturation,and balloon-occluded retrograde transvenous obliteration vs. endoscopic sclerotherapy, transjugular intrahepatic portosystemic shunt, and balloon tamponade (OR=0.221, P<0.001). Rebleeding developed in 11.5% of the patients, and was significantly associated with Child-Pugh score (OR=1.159, P<0.001) and treatment modality (OR=0.619, P=0.026). The GVB-associated mortality was 10.3%; mortality in these cases was associated with Child-Pugh score (OR=1.795, P<0.001)and the treatment modality for the initial hemostasis (OR=0.467, P=0.001). Conclusions: The clinical outcome for GVB was better for the present cohort than in previous reports. Initial hemostasis failure, rebleeding, and mortality due to GVB were universally associated with the severity of liver cirrhosis. (Clin Mol Hepatol 2013;19:36-44)
Abstract
Background/Aims: While gastric variceal bleeding (GVB) is not as prevalent as esophageal variceal bleeding, it is reportedly more serious, with high failure rates of the initial hemostasis (>30%), and has a worse prognosis than esophageal variceal bleeding. However, there is limited information regarding hemostasis and the prognosis for GVB. The aim of this study was to determine retrospectively the clinical outcomes of GVB in a multicenter study in Korea. Methods: The data of 1,308 episodes of GVB (males:females=1062:246, age=55.0±11.0 years, mean±SD) were collected from 24 referral hospital centers in South Korea between March 2003 and December 2008. The rates of initial hemostasis failure, rebleeding, and mortality within 5 days and 6 weeks of the index bleed were evaluated. Results: The initial hemostasis failed in 6.1% of the patients, and this was associated with the Child-Pugh score [odds ratio (OR)=1.619; P<0.001] and the treatment modality: endoscopic variceal ligation, endoscopic variceal obturation,and balloon-occluded retrograde transvenous obliteration vs. endoscopic sclerotherapy, transjugular intrahepatic portosystemic shunt, and balloon tamponade (OR=0.221, P<0.001). Rebleeding developed in 11.5% of the patients, and was significantly associated with Child-Pugh score (OR=1.159, P<0.001) and treatment modality (OR=0.619, P=0.026). The GVB-associated mortality was 10.3%; mortality in these cases was associated with Child-Pugh score (OR=1.795, P<0.001)and the treatment modality for the initial hemostasis (OR=0.467, P=0.001). Conclusions: The clinical outcome for GVB was better for the present cohort than in previous reports. Initial hemostasis failure, rebleeding, and mortality due to GVB were universally associated with the severity of liver cirrhosis. (Clin Mol Hepatol 2013;19:36-44)
참고문헌 (26)
- Sarin SK, "Prevalence, classification and natural history of gastric varices: a longterm follow-up study in 568 portal hypertension patients", Hepatology, 16, pp.1343~1349 (1992)
- Thakeb F, "Endoscopic diagnosis of gastric varices", Endoscopy, 26, pp.287~291 (1994)
- Trudeau W, "Endoscopic injection sclerosis in bleeding gastric varices", Gastrointest Endosc, 32, pp.264~268 (1986)
- Sarin SK, "Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience", Gastrointest Endosc, 46, pp.8~14 (1997)
- Ryan BM, "A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices", Gastroenterology, 126, pp.1175~1189 (2004)
- Sarin SK, "A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices", Am J Gastroenterol, 97, pp.1010~1015 (2002)
- Rengstorff DS, "A pilot study of 2-octyl cyanoacrylate injection for treatment of gastric fundal varices in humans", Gastrointest Endosc, 59, pp.553~558 (2004)
- Rockey DC, "Management of gastric varices", Gastroenterology, 120, pp.1875~1877 (2001)
- Beppu K, "Prediction of variceal hemorrhage by esophageal endoscopy", Gastrointest Endosc, 27, pp.213~218 (1981)
- Pugh RN, "Transection of the oesophagus for bleeding oesophageal varices", Br J Surg, 60, pp.646~649 (1973)
- Wiesner R, "Model for end-stage liver disease (MELD) and allocation of donor livers", Gastroenterology, 124, pp.91~96 (2003)
- de Franchis R, "Developing consensus in portal hypertension", J Hepatol, 25, pp.390~394 (1996)
- de Franchis R, "Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension", J Hepatol, 33, pp.846~852 (2000)
- de Franchis R, "Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension", J Hepatol, 43, pp.167~176 (2005)
- 서연석, "Clinical Features and Treatment Outcomes of Upper Gastrointestinal Bleeding in Patients with Cirrhosis", Journal of Korean Medical Science, 23(4), pp.635~643 (2008), 대한의학회
- 김재우, "위정맥류 출혈 환자에서 N-butyl-2-cyanoacrylate를 이용한 내시경경화요법의 치료 효과", Clinical and Molecular Hepatology, 12(3), pp.394~403 (2006), 대한간학회
- 이충현, "위정맥류의 자연경과와 출혈의 위험인자", Clinical and Molecular Hepatology, 14(3), pp.331~341 (2008), 대한간학회
- de Franchis R, "Natural history of portal hypertension in patients with cirrhosis", Clin Liver Dis, 5, pp.645~663 (2001)
- Lo GH, "A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices", Hepatology, 33, pp.1060~1064 (2001)
- Tan PC, "A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation", Hepatology, 43, pp.690~697 (2006)
- Garcia-Tsao G, "Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis", Hepatology, 46, pp.922~938 (2007)
- Bosch J, "The management of portal hypertension: rational basis, available treatments and future options", J Hepatol, 48(Suppl 1), pp.S68~S92 (2008)
- Jalan R, "UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology", Gut, 46(Suppl 3-4), pp.III1~III15 (2000)
- Gimson AE, "Endoscopic sclerotherapy in the management of gastric variceal haemorrhage", J Hepatol, 13, pp.274~278 (1991)
- Sarin SK, "Management of gastric varices", Baillieres Clin Gastroenterol, 6, pp.527~548 (1992)
- Kind R, "Bucrylate treatment of bleeding gastric varices: 12 years’ experience", Endoscopy, 32, pp.512~519 (2000)